WallStSmart
ORKA

Oruka Therapeutics, Inc.

NASDAQ: ORKA · HEALTHCARE · BIOTECHNOLOGY

$68.41
+0.46% today

Updated 2026-04-30

Market cap
$3.42B
P/E ratio
P/S ratio
EPS (TTM)
$-1.85
Dividend yield
52W range
$9 – $91
Volume
1.3M

Oruka Therapeutics, Inc. (ORKA) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item20052006200720082009201020112012201320142015201620172018201920202021202220232024
Total assets$108.05M$184.41M$120.68M$11.08M$9.37M$8.16M$6.50M$3.21M$17.08M$16.13M$39.57M$24.63M$12.37M$6.83M$8.54M$50.43M$54.92M$43.09M$37.86M$396.02M
Cash & equivalents
Current assets$85.77M$166.34M$99.99M$9.68M$8.29M$7.16M$6.21M$3.04M$16.93M$15.49M$38.92M$21.45M$12.30M$6.78M$8.48M$49.97M$54.42M$42.70M$37.59M$376.87M
Total liabilities$51.28M$114.56M$53.02M$16.39M$1.96M$1.39M$770000.00$305000.00$1.50M$1.39M$1.50M$2.44M$2.09M$793000.00$926000.00$3.91M$3.88M$1.41M$841000.00$13.80M
Current liabilities$36.18M$43.84M$18.19M$15.83M$1.64M$1.19M$754000.00$305000.00$1.50M$1.39M$1.50M$2.40M$2.07M$793000.00$926000.00$3.50M$3.50M$1.13M$637000.00$13.04M
Long-term debt
Shareholder equity
Retained earnings$-327.66M$-458.21M$-470.51M$-40.75M$-49.89M$-58.31M$-63.67M$-67.99M$-74.93M$-84.62M$-96.07M$-112.51M$-131.00M$-138.93M$-144.42M$-154.15M$-173.48M$-183.40M$-188.74M$-83.72M
Accounts receivable$1.21M$8.56M$588000.00
Inventory
Goodwill$4.67M$4.67M$4.67M